E1	Condition:T1 Name:T56
E2	And:T2 Arg:E1 Arg2:E3
E3	Observation:T3 Name:T57 Eq-Comparison:E4
E4	Eq-Comparison:T4 Operator:T58 Value:T59 Temporal-Unit:T60
E5	Observation:T5 Name:T61
E6	Eq-Comparison:T6 Value:T94 Value2:T95
E8	Modifier:T8 Modifies:T63
E9	Procedure:T9 Name:T63
E10	Modifier:T10 Modifies:T64
E11	Procedure:T11 Name:T64
E12	Drug:T12 Name:T65
E13	Drug:T13 Name:T66
E14	Drug:T14 Name:T67
E15	Or:T15 Arg:E14 Arg2:E16
E16	Drug:T16 Name:T68
E17	Drug:T17 Name:T69
E18	Exception:T18 From:E17 Except:E19
E19	Drug:T19 Name:T62
E20	Or:T20 Arg:E17 Arg2:E58
E21	Modifier:T21 Modifies:T70
E22	Procedure:T22 Name:T70
E23	Negation:T23 Negates:E59
E24	Observation:T24 Name:T71 Eq-Comparison:E28
E25	Temporal-Connection:T25 Arg:E24
E26	Temporal-Connection:T26 Arg:E27
E27	Procedure:T27 Name:T72
E28	Eq-Comparison:T28 Operator:T73 Value:T74
E29	Age:T29 Eq-Comparison:E30
E30	Eq-Comparison:T30 Operator:T75 Value:T76
E32	Procedure:T32 Name:T101
E34	Or:T34 Arg:E33 Arg2:E35
E36	Negation:T36 Negates:E38 Negates2:E41
E37	Assertion:T37 Asserted:E38 Asserted2:E41
E38	Procedure:T38 Name:T78
E39	Or:T39 Arg:E38 Arg2:E41
E41	Procedure:T41 Name:T79
E42	Condition:T42 Name:T80
E43	Condition:T43 Name:T81
E44	Drug:T44 Name:T82
E45	Procedure:T45 Name:T83
E47	Procedure:T47 Name:T84
E48	Procedure:T48 Name:T85
E49	Eq-Comparison:T49 Temporal-Period:T86
E50	Condition:T50 Name:T87 Temporality:E49
E51	Procedure:T51 Name:T88
E52	Risk:T52 Risk-For:E55
E53	Temporal-Connection:T53 Arg:E55 Arg2:E54
E54	Procedure:T54 Name:T89
E55	Condition:T55 Name:T90
E56	Modifier:T91 Modifies:T57
E57	Observation:T92 Name:T93 Eq-Comparison:E6
E7	Assertion:T7 Asserted:E9
E58	Negation:T96 Negates:E22
E59	Modifier:T97 Modifies:T70
E60	Assertion:T98 Asserted:E59
E61	Or:T99 Arg:E25 Arg2:E26
E62	Condition:T100 Name:T77
E31	Assertion:T31 Asserted:E32
E63	Negation:T102 Negates:E32
E33	Procedure:T33 Name:T103
E35	Provider:T35 Type:T104
E64	Modifier:T105 Modifies:T104
E40	Modifier:T40 Modifies:T83
E46	Procedure:T46 Name:T106
E65	Temporal-Connection:T107 Arg:E47 Arg2:E48
E66	Assertion:T108 Asserted:E46
T1	Condition 39 42	CPM
T2	And 43 47	with
T3	Observation 57 72	life expectancy
T4	Eq-Comparison 76 86	> 6 months
T5	Observation 93 125	ECOG Scale of Performance Status
T6	Eq-Comparison 131 144	scores 0 or 1
T8	Modifier 199 207	systemic
T9	Procedure 208 220	chemotherapy
T10	Modifier 241 261	Concomitant systemic
T11	Procedure 262 274	chemotherapy
T12	Drug 289 296	FOLFIRI
T13	Drug 298 304	FOLFOX
T14	Drug 306 317	Mitomycin C
T15	Or 318 319	&
T16	Drug 325 337	Fluorouracil
T17	Drug 339 351	Capecitabine
T18	Exception 353 362	excluding
T19	Drug 363 370	Lonsurf
T20	Or 372 374	or
T21	Modifier 383 391	systemic
T22	Procedure 392 404	chemotherapy
T23	Negation 408 410	no
T24	Observation 454 470	Neutrophil count
T25	Temporal-Connection 471 473	on
T26	Temporal-Connection 482 488	before
T27	Procedure 489 501	chemotherapy
T28	Eq-Comparison 514 518	>1.5
T29	Age 544 547	Age
T30	Eq-Comparison 548 551	<18
T32	Procedure 600 605	PIPAC
T34	Or 658 660	or
T36	Negation 698 701	not
T37	Assertion 702 709	fit for
T38	Procedure 710 729	general anaesthesia
T39	Or 730 738	and / or
T41	Procedure 739 750	laparoscopy
T42	Condition 767 788	evident gross ascites
T43	Condition 794 811	Bowel obstruction
T44	Drug 817 828	Bevacizumab
T45	Procedure 849 861	chemotherapy
T47	Procedure 881 893	chemotherapy
T48	Procedure 897 904	surgery
T49	Eq-Comparison 953 961	Previous
T50	Condition 962 985	bone marrow suppression
T51	Procedure 993 1005	chemotherapy
T52	Risk 1012 1016	risk
T53	Temporal-Connection 1020 1024	post
T54	Procedure 1025 1034	operative
T55	Condition 1035 1046	neutropenia
T56	Condition-Name 39 42	CPM
T57	Observation-Name 57 72	life expectancy
T58	Eq-Operator 76 77	>
T59	Eq-Value 78 79	6
T60	Eq-Temporal-Unit 80 86	months
T61	Observation-Name 93 125	ECOG Scale of Performance Status
T63	Procedure-Name 208 220	chemotherapy
T64	Procedure-Name 262 274	chemotherapy
T65	Drug-Name 289 296	FOLFIRI
T66	Drug-Name 298 304	FOLFOX
T67	Drug-Name 306 317	Mitomycin C
T68	Drug-Name 325 337	Fluorouracil
T69	Drug-Name 339 351	Capecitabine
T70	Procedure-Name 392 404	chemotherapy
T71	Observation-Name 454 470	Neutrophil count
T72	Procedure-Name 489 501	chemotherapy
T73	Eq-Operator 514 515	>
T74	Eq-Value 515 518	1.5
T75	Eq-Operator 548 549	<
T76	Eq-Value 549 551	18
T77	Condition-Name 557 560	MDT
T78	Procedure-Name 710 729	general anaesthesia
T79	Procedure-Name 739 750	laparoscopy
T80	Condition-Name 767 788	evident gross ascites
T81	Condition-Name 794 811	Bowel obstruction
T82	Drug-Name 817 828	Bevacizumab
T83	Procedure-Name 849 861	chemotherapy
T84	Procedure-Name 881 893	chemotherapy
T85	Procedure-Name 897 904	surgery
T86	Eq-Temporal-Period 953 961	Previous
T87	Condition-Name 962 985	bone marrow suppression
T88	Procedure-Name 993 1005	chemotherapy
T89	Procedure-Name 1025 1034	operative
T90	Condition-Name 1035 1046	neutropenia
T91	Modifier 48 56	expected
T92	Observation 127 129	PS
T93	Observation-Name 127 129	PS
T94	Eq-Value 138 139	0
T95	Eq-Value 143 144	1
T7	Assertion 174 187	to facilitate
T62	Drug-Name 363 370	Lonsurf
T96	Negation 375 382	without
T97	Modifier 411 419	systemic
T98	Assertion 428 437	available
T99	Or 474 476	or
T100	Condition 557 560	MDT
T101	Procedure-Name 600 605	PIPAC
T31	Assertion 587 595	suitable
T102	Negation 583 586	not
T33	Procedure 623 646	Preoperative Assessment
T103	Procedure-Name 623 646	Preoperative Assessment
T35	Provider 672 684	Anaesthetist
T104	Provider-Type 672 684	Anaesthetist
T105	Modifier 661 671	Consultant
T40	Modifier 840 848	systemic
T46	Procedure 927 932	PIPAC
T106	Procedure-Name 927 932	PIPAC
T107	Temporal-Connection 894 896	to
T108	Assertion 905 913	would be
A1	Temporal-Connection-Type-Value E26 before
A3	Assertion-Type-Value E37 hypothetical
A4	Temporal-Connection-Type-Value E53 after
A5	Eq-Operator-Value T58 GT
A6	Eq-Temporal-Unit-Value T60 month
A7	Observation-Type-Value T61 clinical-score
A8	Observation-Type-Value T71 lab
A9	Eq-Operator-Value T73 GT
A10	Eq-Operator-Value T75 LT
A11	Eq-Temporal-Period-Value T86 past
A12	Assertion-Type-Value E7 hypothetical
A13	Assertion-Type-Value E60 hypothetical
A14	Temporal-Connection-Type-Value E25 during
A15	Assertion-Type-Value E31 hypothetical
A2	Temporal-Connection-Type-Value E65 after
A16	Assertion-Type-Value E66 hypothetical
R1	Abbrev-Of Arg1:E57 Arg2:E5
R2	Using Arg1:E11 Arg2:E12
R3	Using Arg1:E11 Arg2:E13
R4	Using Arg1:E11 Arg2:E14
R5	Using Arg1:E11 Arg2:E16
R6	Using Arg1:E11 Arg2:E17
R7	Treatment-For Arg1:E32 Arg2:E62
R8	Found-By Arg1:E36 Arg2:E33
R9	Found-By Arg1:E36 Arg2:E35
R10	Using Arg1:E45 Arg2:E44
R11	Caused-By Arg1:E50 Arg2:E51
R12	Caused-By Arg1:E55 Arg2:E50